Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial

Future Health ESG (FHLT) Competitors

$11.85
+0.45 (+3.95%)
(As of 05/17/2024 08:53 PM ET)

FHLT vs. ARYD, PTWO, TARA, BNGO, SHOT, TOI, LTRN, VHAQ, TSBX, and PDEX

Should you be buying Future Health ESG stock or one of its competitors? The main competitors of Future Health ESG include ARYA Sciences Acquisition Corp IV (ARYD), Pono Capital Two (PTWO), Protara Therapeutics (TARA), Bionano Genomics (BNGO), Safety Shot (SHOT), Oncology Institute (TOI), Lantern Pharma (LTRN), Viveon Health Acquisition (VHAQ), Turnstone Biologics (TSBX), and Pro-Dex (PDEX). These companies are all part of the "medical" sector.

Future Health ESG vs.

ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD) and Future Health ESG (NASDAQ:FHLT) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, media sentiment, profitability, community ranking, institutional ownership, earnings, valuation and dividends.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ARYA Sciences Acquisition Corp IV
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Future Health ESG
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

ARYA Sciences Acquisition Corp IV and Future Health ESG both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
ARYA Sciences Acquisition Corp IVN/AN/A
Future Health ESGN/AN/A

ARYA Sciences Acquisition Corp IV has a beta of -0.01, indicating that its share price is 101% less volatile than the S&P 500. Comparatively, Future Health ESG has a beta of -0.12, indicating that its share price is 112% less volatile than the S&P 500.

ARYA Sciences Acquisition Corp IV's return on equity of -9.79% beat Future Health ESG's return on equity.

Company Net Margins Return on Equity Return on Assets
ARYA Sciences Acquisition Corp IVN/A -9.83% -5.41%
Future Health ESG N/A -9.79%-0.28%

48.1% of ARYA Sciences Acquisition Corp IV shares are held by institutional investors. Comparatively, 24.6% of Future Health ESG shares are held by institutional investors. 53.5% of ARYA Sciences Acquisition Corp IV shares are held by company insiders. Comparatively, 57.2% of Future Health ESG shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, Future Health ESG had 3 more articles in the media than ARYA Sciences Acquisition Corp IV. MarketBeat recorded 3 mentions for Future Health ESG and 0 mentions for ARYA Sciences Acquisition Corp IV. ARYA Sciences Acquisition Corp IV's average media sentiment score of 0.94 beat Future Health ESG's score of 0.00 indicating that Future Health ESG is being referred to more favorably in the news media.

Company Overall Sentiment
ARYA Sciences Acquisition Corp IV Neutral
Future Health ESG Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ARYA Sciences Acquisition Corp IVN/AN/A-$2.13MN/AN/A
Future Health ESGN/AN/A-$50KN/AN/A

Summary

Future Health ESG beats ARYA Sciences Acquisition Corp IV on 6 of the 8 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FHLT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FHLT vs. The Competition

MetricFuture Health ESGHolding Offices IndustryMedical SectorNASDAQ Exchange
Market Cap$70.35M$377.62M$5.23B$7.98B
Dividend YieldN/A7.49%44.24%3.91%
P/E RatioN/A6.94119.9616.67
Price / SalesN/A21.082,373.9285.85
Price / CashN/A60.3336.8831.98
Price / Book-7.6083.745.504.64
Net Income-$50,000.00$22.68M$105.95M$217.28M
7 Day Performance-0.84%1.09%1.42%2.90%
1 Month Performance10.44%0.40%4.96%6.66%
1 Year PerformanceN/A0.52%7.89%9.89%

Future Health ESG Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ARYD
ARYA Sciences Acquisition Corp IV
0 of 5 stars
$11.37
flat
N/AN/A$85.73MN/A0.003News Coverage
PTWO
Pono Capital Two
0 of 5 stars
$13.00
flat
N/AN/A$67.81MN/A0.00N/AGap Down
TARA
Protara Therapeutics
1.6243 of 5 stars
$3.34
+3.1%
$26.50
+693.4%
+0.3%$68.77MN/A-0.8926Insider Selling
High Trading Volume
BNGO
Bionano Genomics
1.8019 of 5 stars
$1.11
+7.8%
$8.00
+620.7%
-82.9%$68.86M$37.47M-0.18344Gap Up
SHOT
Safety Shot
0 of 5 stars
$1.36
-8.7%
N/AN/A$66.94M$200,000.00-1.928Gap Up
TOI
Oncology Institute
1.6415 of 5 stars
$0.90
+3.4%
$2.25
+150.0%
+48.6%$66.88M$324.24M-0.98800Earnings Report
LTRN
Lantern Pharma
0.3222 of 5 stars
$6.19
+1.6%
N/A+20.6%$66.60MN/A-3.8021
VHAQ
Viveon Health Acquisition
0 of 5 stars
$10.00
flat
N/AN/A$66.50MN/A0.00N/A
TSBX
Turnstone Biologics
2.1016 of 5 stars
$2.87
-5.3%
$19.00
+562.0%
N/A$66.38M$19.31M0.0080
PDEX
Pro-Dex
0 of 5 stars
$19.33
+2.2%
N/A+11.0%$66.09M$49.46M33.33145Positive News

Related Companies and Tools

This page (NASDAQ:FHLT) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners